Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise
beta
Latest Financials
Filings:
By Category
By Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
Company Exhibits:
Indentures
Material Contracts & Credit Agreements
Plans of Reorganization
Articles and Bylaws
Underwriting Agreements
SEC Edgar
Lantheus Holdings, Inc.
SIC 2835 · In Vitro & In Vivo Diagnostic Substances
Notes
Support
about
terms
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
beta
Latest Financials
Filings:
Category
Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
SEC Edgar
Lantheus Holdings, Inc.
SIC 2835 · In Vitro & In Vivo Diagnostic Substances
Notes
Support
about
terms
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
beta
Latest Financials
Filings:
Category
Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
SEC Edgar
Lantheus Holdings, Inc.
SIC 2835 · In Vitro & In Vivo Diagnostic Substances
Notes
Support
about
terms
$
LNTH
Lantheus Holdings, Inc.
CIK:
0001521036
|
SEC Filings
PLANS OF ORGANIZATION
EX-2.1
d167446dex21.htm
2026-08-04T00:00:00Z
EX-2.1
d925405dex21.htm
2025-01-28T00:00:00Z
EX-2.1
d886247dex21.htm
2020-02-20T00:00:00Z
EX-2.1
d886247dex21.htm
2020-02-20T00:00:00Z
EX-2.1
d810725dex21.htm
2019-10-02T00:00:00Z
EX-2.1
d810725dex21.htm
2019-10-02T00:00:00Z
EX-2.1
d233043dex21.htm
2016-08-25T00:00:00Z
EX-2.1
d174529dex21.htm
2016-05-03T00:00:00Z